Target intelligence / Profile preview

PHD finger protein 19 (PHF19)

Target
PHF19
Molecular classification
Epigenetic regulator, Polycomb group protein, Chromatin modifier, Histone mark reader (Tudor domain, PHD finger), Transcription factor, Other (PRC2 complex component)
01

Overview

PHF19 (PHD finger protein 19) is a polycomb group protein and chromatin modifier characterized by a Tudor domain, two PHD fingers, and an extended homologous (EH) domain[1][2]. As a reader of methylated histone marks, especially H3K36me3 and H3K27me3, PHF19 recruits the Polycomb repressive complex 2 (PRC2), enhancing its methylation activity and facilitating the transition from transcriptionally active to repressed chromatin states. This function is crucial in embryonic stem cell self-renewal and lineage determination, as PHF19 mediates the deposition of repressive H3K27me3 marks by activating PRC2 and recruiting demethylases (e.g., KDM2B)[1][2]. PHF19 is implicated in diseases such as melanoma and rheumatoid arthritis, primarily through its role in gene silencing and cellular differentiation; aberrant PHF19 activity or expression has been associated with tumorigenesis and autoimmune pathogenesis[2]. While no drugs currently target PHF19 directly, its unique histone interaction surfaces have been structurally characterized, potentially enabling future inhibitor or chemical probe development[1].

Other names
PCL3hPCL3DKFZP727G051MTF2L1TDRD19BPolycomb-like protein 3polycomb-like 3tudor domain containing 19B
02

Mechanism of action

Not applicable

03

Biological functions

Histone mark recognition (H3K36me3, H3K27me3, H3tK27me3)Negative regulation of gene expressionChromatin silencingPromotion of H3K27 trimethylation through PRC2 recruitmentEmbryonic stem cell self-renewalRecruitment of histone demethylases and chromatin modifiers
04

Disease associations

Cancer (e.g., melanoma)Autoimmune disease (e.g., rheumatoid arthritis)Other (role in stem cell biology and developmental disorders possible due to chromatin silencing activity)
05

Safety considerations

Epigenetic off-target effectsPotential for stem cell dysregulation and cancer progression
06

Biomarkers

H3K36me3 enrichment/localizationPHF19 expression level

Beyond the preview

Go deeper on PHD finger protein 19 (PHF19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHD finger protein 19 (PHF19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call